Regenxbio Inc
NASDAQ:RGNX

Watchlist Manager

Regenxbio Inc

NASDAQ:RGNX

Watchlist

Dividends

Price: 8.68 USD -4.19% Market Closed

Market Cap: 435.4m USD

Activate Unlimited Plan
to continue RGNX research

You've reached your weekly stock limit.

14-day money-back guarantee

Have any thoughts about
Regenxbio Inc?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication
US	Chevron Corp NYSE:CVX	Energy

Add Price Alert

Price Target:

Last Price: 8.68 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching false

Delete

Cancel

RGNX Alert

Regenxbio Inc

8.68

-0.38 (-4.19%)

52 Week Range	5.31 14.39
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US
	Chevron Corp NYSE:CVX	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Regenxbio Inc

What unique competitive advantages
does Regenxbio Inc hold over its rivals?

What risks and challenges
does Regenxbio Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Regenxbio Inc.

What unique competitive advantages
does Regenxbio Inc hold over its rivals?

What risks and challenges
does Regenxbio Inc face in the near future?

Has there been any significant insider trading activity
in Regenxbio Inc recently?

Summarize the latest earnings call
of Regenxbio Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Regenxbio Inc.

Provide P/S
for Regenxbio Inc.

Provide P/E
for Regenxbio Inc.

Provide P/OCF
for Regenxbio Inc.

Provide P/FCFE
for Regenxbio Inc.

Provide P/B
for Regenxbio Inc.

Provide EV/S
for Regenxbio Inc.

Provide EV/GP
for Regenxbio Inc.

Provide EV/EBITDA
for Regenxbio Inc.

Provide EV/EBIT
for Regenxbio Inc.

Provide EV/OCF
for Regenxbio Inc.

Provide EV/FCFF
for Regenxbio Inc.

Provide EV/IC
for Regenxbio Inc.

Show me price targets
for Regenxbio Inc made by professional analysts.

What are the Revenue projections
for Regenxbio Inc?

How accurate were the past Revenue estimates
for Regenxbio Inc?

What are the Net Income projections
for Regenxbio Inc?

How accurate were the past Net Income estimates
for Regenxbio Inc?

What are the EPS projections
for Regenxbio Inc?

How accurate were the past EPS estimates
for Regenxbio Inc?

What are the EBIT projections
for Regenxbio Inc?

How accurate were the past EBIT estimates
for Regenxbio Inc?

Compare the revenue forecasts
for Regenxbio Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Regenxbio Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Regenxbio Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Regenxbio Inc compared to its peers.

Compare the P/E ratios
of Regenxbio Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Regenxbio Inc with its peers.

Analyze the financial leverage
of Regenxbio Inc compared to its main competitors.

Show all profitability ratios
for Regenxbio Inc.

Provide ROE
for Regenxbio Inc.

Provide ROA
for Regenxbio Inc.

Provide ROIC
for Regenxbio Inc.

Provide ROCE
for Regenxbio Inc.

Provide Gross Margin
for Regenxbio Inc.

Provide Operating Margin
for Regenxbio Inc.

Provide Net Margin
for Regenxbio Inc.

Provide FCF Margin
for Regenxbio Inc.

Show all solvency ratios
for Regenxbio Inc.

Provide D/E Ratio
for Regenxbio Inc.

Provide D/A Ratio
for Regenxbio Inc.

Provide Interest Coverage Ratio
for Regenxbio Inc.

Provide Altman Z-Score Ratio
for Regenxbio Inc.

Provide Quick Ratio
for Regenxbio Inc.

Provide Current Ratio
for Regenxbio Inc.

Provide Cash Ratio
for Regenxbio Inc.

What is the historical Revenue growth
over the last 5 years for Regenxbio Inc?

What is the historical Net Income growth
over the last 5 years for Regenxbio Inc?

What is the current Free Cash Flow
of Regenxbio Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Regenxbio Inc.

Wall Street Price Targets Revenue Forecast Operating Income Forecast Net Income Forecast See Also

Section:

Wall Street Price Targets

Revenue Forecast

Operating Income Forecast

Net Income Forecast

Wall Street
Price Targets

RGNX Price Targets Summary
Regenxbio Inc

Wall Street analysts forecast RGNX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RGNX is 32.39 USD with a low forecast of 13.13 USD and a high forecast of 54.6 USD.

RGNX Average Forecast

Wall Street Target

32.39 USD

273% Upside

RGNX Highest Forecast

Wall Street Target

54.6 USD

529% Upside

Lowest

Price Target

13.13 USD

51% Upside

Average

Price Target

32.39 USD

273% Upside

Highest

Price Target

54.6 USD

529% Upside

Regenxbio Inc Competitors:
Price Targets

688428

InnoCare Pharma Ltd

18% Downside

CRSP

CRISPR Therapeutics AG

44% Upside

HPHA

Heidelberg Pharma AG

169% Upside

4587

PeptiDream Inc

120% Upside

688428

InnoCare Pharma Ltd

18% Downside

CRSP

CRISPR Therapeutics AG

44% Upside

HPHA

Heidelberg Pharma AG

169% Upside

4587

PeptiDream Inc

120% Upside

BRNS

Barinthus Biotherapeutics PLC

359% Upside

301080

Acrobiosystems Co Ltd

17% Upside

603087

Gan & Lee Pharmaceuticals

11% Upside

AMRN

Amarin Corporation PLC

19% Downside

Revenue
Forecast

Revenue Estimate
Regenxbio Inc

For the last 8 years the compound annual growth rate for Regenxbio Inc's revenue is 44%. The projected CAGR for the next 3 years is 59%.

44%

Past Growth

59%

Estimated Growth

Estimates Accuracy

-12%

Average Miss

What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Regenxbio Inc

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

Average Beat

What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Regenxbio Inc

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-12%

Average Miss

What are analyst estimates?

What is RGNX's stock price target?

Price Target
32.39 USD

According to Wall Street analysts, the average 1-year price target for RGNX is 32.39 USD with a low forecast of 13.13 USD and a high forecast of 54.6 USD.

What is Regenxbio Inc's Revenue forecast?

Projected CAGR
59%

For the last 8 years the compound annual growth rate for Regenxbio Inc's revenue is 44%. The projected CAGR for the next 3 years is 59%.

	Regenxbio Inc NASDAQ:RGNX	8.68 USD -4.19%
	Roolife Group Ltd ASX:RLG	0.004 AUD
	BB Seguridade Participacoes SA BOVESPA:BBSE3	35.22 BRL -0.23%
	Energizer Holdings Inc F:EGG	19.3 EUR 3.76%
	Australian Vanadium Ltd ASX:AVL	0.008 AUD
	Luminar Technologies Inc NASDAQ:LAZR	2.77 USD -3.82%

	Franklin Covey Co NYSE:FC	19.87 USD -4.7%
	Mohawk Industries Inc NYSE:MHK	112.53 USD -1.14%
	Ardmore Shipping Corp NYSE:ASC	10.48 USD 1.16%
	ASGN Inc NYSE:ASGN	48.62 USD -3.76%
	Skyworks Solutions Inc NASDAQ:SWKS	75.42 USD -2.93%
	Weatherford International PLC NASDAQ:WFRD	58.15 USD 1.57%

	Johnson & Johnson NYSE:JNJ	156.9 USD -0.5%
	Bank of America Corp NYSE:BAC	46.73 USD -0.51%
	Mastercard Inc NYSE:MA	550.18 USD -2.37%
	Salesforce Inc NYSE:CRM	258.07 USD -2.24%
	Abbvie Inc NYSE:ABBV	192.45 USD -1.31%
	Home Depot Inc NYSE:HD	370.07 USD -0.87%

	Monolithic Power Systems Inc NASDAQ:MPWR	736.06 USD -0.59%
	NVIDIA Corp NASDAQ:NVDA	164.92 USD 0.5%
	Pro Medicus Ltd ASX:PME	317.34 AUD -0.11%
P	Plover Bay Technologies Ltd HKEX:1523	6.15 HKD 0.65%
S	SciClone Pharmaceuticals (Holdings) Ltd HKEX:6600	18.72 HKD
	Alfa Financial Software Holdings PLC LSE:ALFA	220 GBX 0.69%

	Salesforce Inc NYSE:CRM	258.07 USD -2.24%
	Accenture PLC NYSE:ACN	281.06 USD -2.53%
	ServiceNow Inc NYSE:NOW	938.78 USD -3.03%
	Spotify Technology SA NYSE:SPOT	709.15 USD -0.11%
	EOG Resources Inc NYSE:EOG	123.04 USD 1.08%
	Monster Beverage Corp NASDAQ:MNST	58.83 USD -0.57%

Regenxbio Inc
NASDAQ:RGNX